title: BDNF-TrkB signaling pathway is involved in pentylenetetrazole-evoked progression of epileptiform activity in hippocampal neurons in anesthetized rats.
abstract: Pentylenetetrazole (PTZ) is a widely-used convulsant used in studies of epilepsy; its subcutaneous injection generates an animal model with stable seizures. Here, we compared the ability of PTZ via the intravenous and subcutaneous routes to evoke progressive epileptiform activity in the hippocampal CA1 neurons of anesthetized rats. The involvement of the BDNF-TrkB pathway was then investigated. When PTZ was given intravenously, it induced epileptiform bursting activity at a short latency in a dose-dependent manner. However, when PTZ was given subcutaneously, it induced a slowly-developing pattern of epileptogenesis; first, generating multiple population-spike peaks, then spontaneous interictal discharge-like spike, leading to the final ictal discharge-like, highly synchronized bursting fi ring in the CA1 pyramidal layer of the hippocampus. K252a, a TrkB receptor antagonist, when given by intracerebroventricular injection, significantly reduced the probability of multiple population spike peaks induced by subcutaneous injection of PTZ, delayed the latency of spontaneous spikes, and reduced the burst frequency. Our results indicate that PTZ induces a progressive change of neuronal epileptiform activity in the hippocampus, and the BDNF-TrkB signaling pathway is mainly involved in the early phases of epileptogenesis, but not the synchronized neuronal burst activity associated with epileptic seizure in the PTZ animal model. These results provide basic insights into the changing pattern of hippocampal neuronal activity during the development of the PTZ seizure model, and establish an in vivo seizure model useful for future electrophysiological studies of epilepsy.
authors.affiliation: Neurology Department, Zhongshan Hospital, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, 200032, China.
authors.forename: Xu
authors.initials: X
authors.lastname: Liu
authors.forename: Jia
authors.initials: J
authors.lastname: Liu
authors.forename: Juan
authors.initials: J
authors.lastname: Liu
authors.forename: Xiao-Ling
authors.initials: XL
authors.lastname: Liu
authors.forename: Ling-Yan
authors.initials: LY
authors.lastname: Jin
authors.forename: Wei
authors.initials: W
authors.lastname: Fan
authors.forename: Jin
authors.initials: J
authors.lastname: Ding
authors.forename: Li-Chao
authors.initials: LC
authors.lastname: Peng
authors.forename: Yun
authors.initials: Y
authors.lastname: Wang
authors.forename: Xin
authors.initials: X
authors.lastname: Wang
mesh_terms: D061605:Administration, Intravenous; D000768:Anesthesia, General; D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism*; D056547:CA1 Region, Hippocampal / Q000187:drug effects / Q000502:physiology; D003292:Convulsants / Q000008:administration & dosage / Q000633:toxicity*; D004195:Disease Models, Animal; D004827:Epilepsy / Q000139:chemically induced / Q000503:physiopathology; D005071:Evoked Potentials; D055104:Infusions, Subcutaneous; D007276:Injections, Intraventricular; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D010433:Pentylenetetrazole / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D020813:Receptor, trkB / Q000378:metabolism*; D012640:Seizures / Q000139:chemically induced* / Q000503:physiopathology; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D003292:Convulsants; D020813:Receptor, trkB; D010433:Pentylenetetrazole
references.citation: J Neurosci Res. 2005 Jan 1-15;79(1-2):48-54
references.pmid: 15562439
references.citation: Nature. 1995 Mar 30;374(6521):450-3
references.pmid: 7700353
references.citation: Nature. 1999 Oct 28;401(6756):918-21
references.pmid: 10553907
references.citation: J Neurosci. 2004 Jul 28;24(30):6842-52
references.pmid: 15282290
references.citation: EMBO J. 1982;1(5):549-53
references.pmid: 7188352
references.citation: Epilepsia. 2003 Apr;44(4):507-17
references.pmid: 12680999
references.citation: Epilepsy Res Suppl. 1991;4:225-45
references.pmid: 1815605
references.citation: Annu Rev Neurosci. 2001;24:677-736
references.pmid: 11520916
references.citation: Learn Mem. 2011 Jul 26;18(8):534-44
references.pmid: 21791566
references.citation: J Neurosci. 2000 Oct 1;20(19):7417-23
references.pmid: 11007900
references.citation: Brain Res Mol Brain Res. 2000 May 31;78(1-2):1-14
references.pmid: 10891580
references.citation: Exp Neurol. 2002 Apr;174(2):201-14
references.pmid: 11922662
references.citation: Eur J Neurosci. 2002 Feb;15(4):721-34
references.pmid: 11886452
references.citation: Proc Natl Acad Sci U S A. 1990 Oct;87(20):8060-4
references.pmid: 2236018
references.citation: Epilepsy Behav. 2011 Feb;20(2):267-76
references.pmid: 21239233
references.citation: Mol Cell Neurosci. 1996 Mar;7(3):222-38
references.pmid: 8726105
references.citation: Epilepsia. 2011 Mar;52(3):572-8
references.pmid: 21269288
references.citation: Seizure. 2011 May;20(4):312-9
references.pmid: 21269843
references.citation: Prog Neurobiol. 2005 Oct;77(3):166-200
references.pmid: 16307840
references.citation: J Pharmacol Sci. 2003 Apr;91(4):267-70
references.pmid: 12719654
references.citation: Science. 1995 Mar 17;267(5204):1658-62
references.pmid: 7886457
references.citation: Ann Neurol. 2001 Aug;50(2):188-94
references.pmid: 11506401
references.citation: Exp Neurol. 1995 Jun;133(2):215-24
references.pmid: 7649227
references.citation: Prog Brain Res. 2007;163:371-97
references.pmid: 17765730
references.citation: Bioessays. 2004 Nov;26(11):1185-94
references.pmid: 15499580
references.citation: Commun Integr Biol. 2009;2(1):14-6
references.pmid: 19704856
references.citation: Genomics. 1991 Jul;10(3):558-68
references.pmid: 1889806
references.citation: Neuroscience. 1999;93(4):1491-506
references.pmid: 10501474
references.citation: Curr Opin Neurobiol. 2001 Jun;11(3):272-80
references.pmid: 11399424
references.citation: J Appl Physiol (1985). 2012 Oct 15;113(8):1260-6
references.pmid: 22936723
references.citation: Prog Neurobiol. 2002 Oct;68(3):167-207
references.pmid: 12450487
references.citation: Trends Neurosci. 2001 Jan;24(1):47-53
references.pmid: 11163887
references.citation: Brain Res. 2010 Oct 8;1355:207-13
references.pmid: 20678492
references.citation: J Neurosci. 2002 Sep 1;22(17):7502-8
references.pmid: 12196573
references.citation: Neuroscience. 1998 Mar;83(2):351-62
references.pmid: 9460745
references.citation: Trends Neurosci. 1998 Apr;21(4):167-74
references.pmid: 9554727
references.citation: J Physiol. 2006 Mar 15;571(Pt 3):605-18
references.pmid: 16423850
references.citation: Hippocampus. 2010 Jun;20(6):713-23
references.pmid: 19603519
references.citation: Brain Behav Immun. 2010 Nov;24(8):1354-61
references.pmid: 20599496
references.citation: J Neurophysiol. 1998 Apr;79(4):1726-32
references.pmid: 9535942
references.citation: Growth Factors. 2004 Sep;22(3):123-31
references.pmid: 15518235
references.citation: Brain Res. 2003 Jun 27;976(2):227-33
references.pmid: 12763257
references.citation: Neurosci Lett. 2006 Jan 9;392(1-2):154-8
references.pmid: 16242239
references.citation: Neurosci Lett. 2002 Nov 22;333(2):103-6
references.pmid: 12419491
references.citation: Neurosci Lett. 2004 Sep 9;367(3):344-8
references.pmid: 15337263
references.citation: Brain Res. 2012 Feb 23;1439:1-6
references.pmid: 22265706
references.citation: Neuropharmacology. 2009 Jul;57(1):49-59
references.pmid: 19393251